R&G PharmaStudies301333 
$5.500.70%24h
0.70%24h
Global rank11105
Market cap$527.54M
Change 7d-1.77%
YTD Performance-39.66%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of R&G PharmaStudies (301333)
As of November 2024, R&G PharmaStudies has a market cap of $527.54M. This makes R&G PharmaStudies the world's 11105th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of R&G PharmaStudies from 2022 to 2024
-
Value:-
Market cap history of R&G PharmaStudies from 2022 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $656.07M | -24.95% |
| 2023 | $874.22M | -21.69% |
| 2022 | $1.12B | - |
301333 Market Cap Today is $527.54M 0.70% - 9 Nov 2024
View largest stocks by market cap 
